Britain has become the first country in the world to approve a potential game-changing COVID-19 antiviral pill, which was jointly developed by US based Merck & Co Inc and Ridgeback Biotherapeutics, in its effort to fight the Wuhan Coronavirus. Britain’s Medicines… Read More ›
obesity
Novo Nordisk acquires Prothena Corp’s experimental heart therapy PRX004
In a joint statement Danish drugmaker Novo Nordisk and U.S. drug developer Prothena Corp said, the former will acquire the latter’s experimental heart therapy PRX004, in a deal that could be worth up to $1.23 billion. Novo’s acquisition is in… Read More ›